Application

17026375 · IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4(PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION

Filed 2020-09-21 · Abandoned The official file ↗ · Art unit 1626 · Examiner Matthew P Coughlin Typical · UNIVERSITÉ DE MONTRÉAL · Bristol-Myers Squibb Company

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

12.4 mo

to disposition 24.4 mo

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.